Transcatheter Aortic Valve Replacement (TAVR) is an innovative technique for treating aortic valve disease. This minimally invasive option is designed for patients at moderate, high, or extreme risk for traditional open-heart surgery. During the procedure, the diseased aortic valve, which does not open properly, is replaced with a new valve, restoring blood flow and alleviating the symptoms associated with aortic stenosis.

Benefits of TAVR:

• It enhances the quality of life for patients with aortic stenosis who are unable to undergo surgery or where surgery poses significant risks.
• TAVR can lower the risk of mortality.
• The procedure alleviates symptoms of aortic valve stenosis and contributes to improved overall health.
• Patients typically enjoy faster recovery times and can often return to their normal activities more quickly.